NDA Partners Revenue and Competitors
Estimated Revenue & Valuation
- NDA Partners's estimated annual revenue is currently $14.8M per year.
- NDA Partners's estimated revenue per employee is $198,000
Employee Data
- NDA Partners has 75 Employees.
- NDA Partners grew their employee count by 4% last year.
NDA Partners's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Consultant | Reveal Email/Phone |
NDA Partners Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.5M | 58 | 7% | N/A | N/A |
#2 | $1.5M | 11 | N/A | N/A | N/A |
#3 | $2M | 15 | -12% | N/A | N/A |
#4 | $6.5M | 37 | -26% | N/A | N/A |
#5 | $8.1M | 46 | -10% | N/A | N/A |
#6 | $748.7M | 3007 | 5% | N/A | N/A |
#7 | $10.5M | 53 | -31% | N/A | N/A |
#8 | $93.8M | 419 | 3% | N/A | N/A |
#9 | $24.2M | 110 | -8% | N/A | N/A |
#10 | $21.8M | 99 | 5% | N/A | N/A |
What Is NDA Partners?
NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP), an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.
keywords:Healthcare,Pharmaceuticals
N/A
Total Funding
75
Number of Employees
$14.8M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NDA Partners News
According to him, Ghana's development partners had the technical expertise and resources to support the country's development efforts.
Ghana: At NDA Multi Stakeholder Consultation - Veep Urges Devt ... country will fail without the active involvement of development partners.
JD(U)'s Upendra Kushwaha cites 'lack of coordination among NDA partners' for BJP's defeat in Bochahan bypoll. In the recently concluded by-...
Dr. Roy’s expertise in respiratory health and airborne infectious diseases with an emphasis on product development for highly infectious agents will be valuable to our clients developing therapies and vaccines for communicable airborne diseases. ROCHELLE, Va. (PRWEB) November 18, 2021 NDA Part ...
Dr. Gombar’s extensive experience in program management and development strategy for drugs, drug delivery systems, and combination products make him a valuable resource to our clients who need support for their entire product development program. ROCHELLE, Va. (PRWEB) June 23, 2021 NDA Partner ...
Other Companies in Rochelle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 85 | 8% | N/A |
#2 | $31.9M | 127 | 9% | N/A |
#3 | $35M | 149 | 38% | N/A |
#4 | $49.3M | 166 | 8% | N/A |